Antibody therapy for histoplasmosis

Frontiers in Microbiology

Volumn 3, Issue FEB, 2012, Pages

  Nosanchuk, Joshua D ^a   Zancopé Oliveira, Rosely M ^b   Hamilton, Andrew J ^c   Guimarães, Allan J ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Funda??o Oswaldo Cruz   (Brazil)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antibody; Co stimulation; Heat shock protein 60; Histone 2B; Histoplasma capsulatum; Histoplasmosis; M antigen

Indexed keywords

EID: 84864451340     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00021     Document Type: Article

References (91)

1. Allen, H. L., and Deepe, G. S. Jr. (2006). B cells and CD4-CD8-T cells are key regulators of the severity of reactivation histoplasmosis. J. Immunol. 177, 1763-1771.
2. Allendoerfer, R., Biovin, G. P., and Deepe, G. S. Jr. (1997). Modulation of immune responses in murine pulmonary histoplasmosis. J. Infect. Dis. 175, 905-914.
3. Allendorfer, R., Brunner, G. D., and Deepe, G. S. Jr. (1999). Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J. Immunol. 162, 7389-7396.
4. Alteras, I. (1966). First Romanian isolation of Histoplasma capsulatum from the soil. Dermatol. Int. 5, 69-71.
5. Bradsher, R. W. (1996). Histoplasmosis and blastomycosis. Clin. Infect. Dis. 22, S102-S111.
6. Briles, D. E., Crain, M. J., Gray, B. M., Forman, C., and Yother, J. (1992a). Strong association between capsu-lar type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60, 111-116.
7. Briles, D. E., Forman, C., and Crain, M. (1992b). Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect. Immun. 60, 1957-1962.
8. Cain, J. A., and Deepe, G. S. Jr. (1998). Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. 66, 1473-1481.
9. Casadevall, A. (1998). Antibody-mediated protection against intracellular pathogens. Trends Microbiol. 6, 102-107.
10. Casadevall, A., Cassone, A., Bistoni, F., Cutler, J. E., Magliani, W., Murphy, J. W., Polonelli, L., and Romani, L. (1998). Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary disputeMed. Mycol. 36(Suppl. 1), 95-105.
11. Chandler, J. W. Jr., Smith, T. K., New-berry, W. M. Jr., Chin, T. D., and Kirkpatrick,C. H. (1969). Immunology of the mycoses. II. Characterization of the immunoglob-ulin and antibody responses in histoplasmosis. J. Infect. Dis. 119, 247-254.
12. Chu, J. H., Feudtner, C., Heydon, K., Walsh, T. J., and Zaoutis, T. E. (2006). Hospitalizations for endemic mycoses: a population-based national study. Clin. Infect. Dis. 42, 822-825.
13. Darling, S. T. (1906). A protozoan general infection producing pseudo-tubercles in the lungs and focal necrosis in the liver, spleen and lymph nodes. J. Am. Med. Assoc. 46, 1283-1285.
14. Deepe, G. S. Jr. (2005). Modulation of infection with Histoplasma capsula-tum by inhibition of tumor necrosis factor-alpha activity. Clin. Infect. Dis. 41(Suppl. 3), S204-S207.
15. Deepe, G. S. Jr., Gibbons, R., Brun-ner, G. D., and Gomez, F. J. (1996). A protective domain of heat-shock protein 60 from Histo-plasma capsulatum. J. Infect. Dis. 174, 828-834.
16. Deepe, G. S. Jr., and Gibbons, R. S. (2002). Cellular and molecular regulation of vaccination with heat shock protein 60 from Histo-plasma capsulatum. Infect. Immun. 70, 3759-3767.
17. Deepe,G. S. Jr.,Gibbons, R. S.,and Smu-lian, A. G. (2008). Histoplasma cap-sulatum manifests preferential invasion of phagocytic subpopulations in murine lungs. J. Leukoc. Biol. 84, 669-678.
18. Deepe, G. S. Jr., Smelt, S., and Louie, J. S. (2005). Tumor necrosis factor inhibition and opportunistic infections. Clin. Infect. Dis. 41(Suppl. 3), S187-S188.
19. Disalvo, A. F., Bigler, W. J., Ajello, L., Johnson, J. E., and Palmer, J. (1970). Bat and soil studies for sources of histoplasmosis in Florida. Public Health Rep. 85, 1063-1069.
20. Dodd, K., and Thompkins, E. H. (1934). Case of histoplasmosis of darling in a infant. Am. J. Trop. Med. Hyg. 14, 127-137.
21. Domer, J. E. (1971). Monosaccharide and chitin content of cell walls of Histoplasma capsulatum and Blasto-myces dermatitidis. J. Bacteriol. 107, 870-877.
22. Dromer, F., Charreire, J., Contrepois, A., Carbon, C., and Yeni, P. (1987). Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55, 749-752.
23. Edwards, L. B., Acquaviva, F. A., Livesay, V. T., Cross, F. W., and Palmer, C. E. (1969). An atlas of sensitivity to tuberculin, PPD-B, and histoplas-min in the United States. Am. Rev. Respir. Dis. 99(Suppl.), 1-132.
24. Eissenberg, L. G., and Goldman, W. E. (1987). Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect. Immun. 55, 29-34.
25. Emmons, C. W. (1950). Histoplasmosis: animal reservoirs and other sources in nature of the pathogenic fungus Histoplasma capsulatum. Am. J. Public Health 40, 436-440.
26. Emmons, C. W. (1956a). Histoplasmo-sis in animals. Public Health Monogr. 70, 272-273.
27. Emmons, C. W. (1956b). Isolation of Histoplasma capsulatum from soil. Public Health Monogr. 70, 237-239.
28. Emmons, C. W., Klite, P. D., Baer, G. M., and Hill,W. B. Jr. (1966). Isolation of Histoplasma capsulatum from bats in the United States. Am. J. Epidemiol. 84, 103-109.
29. Fojtasek, M. F., Kleiman, M. B., Connolly-Stringfield, P., Blair, R., and Wheat, L. J. (1994). The Histo-plasma capsulatum antigen assay in disseminated histoplasmosis in children. Pediatr. Infect. Dis. J. 13, 801-805.
30. Fojtasek, M. F., Sherman, M. R., Gar-ringer, T., Blair, R., Wheat, L. J., and Schnizlein-Bick, C. T. (1993). Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis. Infect. Immun. 61, 4607-4614.
31. Gomez, B. L., Figueroa, J. I., Hamilton, A. J., Diez, S., Rojas, M., Tobon, A., Restrepo, A., and Hay, R. J. (1999). Detection of the 70-kilodalton Histoplasma capsulatum antigen in serum of histoplasmosis patients: correlation between anti-genemia and therapy during follow-up. J. Clin. Microbiol. 37, 675-680.
32. Gomez, B. L., Figueroa, J. I., Hamilton, A. J., Ortiz, B. L., Robledo, M. A., Restrepo, A., and Hay, R. J. (1997). Development of a novel antigen detection test for histoplasmosis. J. Clin. Microbiol. 35, 2618-2622.
33. Goodwin, R. A. Jr., and Des Prez, R. M. (1978). State of the art: histo-plasmosis. Am. Rev. Respir. Dis. 117, 929-956.
34. Goodwin,R.A.,Loyd,J.E.,and DesPrez, R. M. (1981). Histoplasmosis in normal hosts. Medicine (Baltimore) 60, 231-266.
35. Guimaraes, A. J., Frases, S., Gomez, F. J., Zancope-Oliveira, R. M., and Nosanchuk, J. D. (2009). Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect. Immun. 77, 1357-1367.
36. Guimaraes, A. J., Hamilton, A. J., De, M. G. H. L., Nosanchuk, J. D., and Zancope-Oliveira,R. M. (2008). Biological function and molecular mapping of M antigen in yeast phase of Histoplasma capsulatum. PLoS ONE 3, e3449. doi:10.1371/jour-nal.pone.0003449
37. Guimaraes, A. J., Frases, S., Pontes, B., De Cerqueira, M. D., Rodrigues, M. L., Viana, N. B., Nimrichter, L., and Nosanchuk,J.D. (2011a). Agglutination of Histoplasma capsulatum by IgG monoclonal antibodies against Hsp60 impacts macrophage effector functions. Infect. Immun. 79, 918- 927.
38. Guimaraes, A. J., Martinez, L. R., and Nosanchuk, J. D. (2011b). Passive administration of monoclonal antibodies against H. capsulatum and other fungal pathogens. J. Vis. Exp. doi:10.3791/2532. Available at: http://www.ncbi.nlm.nih.gov/ entrez/query.fcgicmd=Retrieve& db=PubMed&dopt=Citation& list_uids=21372781
39. Guimaraes, A. J., Nakayasu, E. S., Sobreira, T. J., Cordero, R. J., Nim-richter, L., Almeida, I. C., and Nosanchuk, J. D. (2011c). Histo-plasma capsulatum heat-shock 60 orchestrates the adaptation of the fungus to temperature stress. PLoS ONE 6, e14660. doi:10.1371/jour-nal.pone.0014660
40. Guimaraes, A. J., Nosanchuk, J. D., and Zancope-Oliveira, R. M. (2006). Diagnosis of histoplasmosis. Braz. J. Microbiol. 37, 1-13.
41. Habich, C., Kempe, K., Gomez, F. J., Lil-licrap, M., Gaston, H., Van der Zee, R., Kolb, H., and Burkart, V. (2006). Heat shock protein 60: identification of specific epitopes for binding to primary macrophages. FEBS Lett. 580, 115-120.
42. Huffnagle, G. B., and Deepe, G. S. (2003). Innate and adaptive determinants of host susceptibility to medically important fungi. Curr. Opin. Microbiol. 6, 344-350.
43. Isbister, J., Elliott, M., and Nogrady, S. (1976). Histoplasmosis: an outbreak occurring among young men who visited one cave. Med. J. Aust. 2, 243-248.
44. Kasuga, T., White, T. J., Koenig, G., Mcewen, J., Restrepo, A., Castaneda, E., Da Silva Lacaz, C., Heins-Vaccari, E. M., De Freitas, R. S., Zancope-Oliveira, R. M., Qin, Z., Negroni, R., Carter, D. A., Mikami, Y., Tamura, M., Taylor, M. L., Miller, G. F., Poonwan, N., and Taylor, J. W. (2003). Phylogeography of the fungal pathogen Histoplasma capsula-tum. Mol. Ecol. 12, 3383-3401.
45. Kauffman, C. A. (2007). Histoplasmo-sis: a clinical and laboratory update. Clin. Microbiol. Rev. 20, 115-132.
46. Kozel, T. R., and McGaw, T. G. (1979). Opsonization of Cryptococcus neo-formans by human immunoglobu-lin G: role of immunoglobulin G in phagocytosis by macrophages. Infect. Immun. 25, 255-261.
47. Lazar-Molnar, E., Gacser, A., Freeman, G. J., Almo, S. C., Nathenson, S. G., and Nosanchuk, J. D. (2008). The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma cap-sulatum. Proc. Natl. Acad. Sci. U.S.A. 105, 2658-2663.
48. Lendvai, N., and Casadevall, A. (1999). Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype. J. Infect. Dis. 180, 791-801.
49. Limaye, A. P., Connolly, P. A., Sagar, M., Fritsche, T. R., Cookson, B. T., Wheat, L. J., and Stamm, W. E. (2000). Transmission of Histo-plasma capsulatum by organ transplantation. N. Engl. J. Med. 343, 1163-1166.
50. Lockhart, S. R., Diekema, D. J., and Pfaller, M. A. (2009). "The epidemiology of fungal infections," in Clinical Mycology, eds E. J. Anaissie, M. R. McGinnis, and M. A. Pfaller (Oxford: Elsevier Inc.)
51. Long, K. H., Gomez, F. J., Morris, R. E., and Newman, S. L. (2003). Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J. Immunol. 170, 487-494.
52. Lopes, L. C., Guimaraes, A. J., De Cerqueira, M. D., Gomez, B. L., and Nosanchuk, J. D. (2010). A Histoplasma capsulatum-specific IgG1 isotype monoclonal antibody, H1C, to a 70-kilodalton cell surface protein is not protective in murine histoplasmosis. Clin. Vaccine Immunol. 17, 1155-1158.
53. Louria, D. B., and Kaminski, T. (1965). Passively-acquired immunity in experimental cryptococcosis. Sabouraudia 4, 80-84.
54. Maresca, B., and Kobayashi, G. S. (1989). Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi. Microbiol. Rev. 53, 186-209.
55. Marques,M.A.M., Mahapatra,S., Nan-dan, D., Dick, T., Sarno, E. N., and Pessolani, M. C. V. (2000). Bacterial and host-derived cationic proteins bind a2-laminins and enhance Mycobacterium leprae attachment to human Schwann cells. Microbes Infect. 2, 1407-1417.
56. Marques, M. A. M., Mahapatra, S., Sarno, E. N., Santos, S., Spencer, J. S., Brennan, P. J., and Pessolani, M. C. V. (2001). Further biochemical characterization of Mycobacterium lep-rae laminin-binding proteins. Braz. J. Med. Biol. Res. 34, 463-470.
57. Martinez, L. R., Mihu, M. R., Gacser, A., Santambrogio, L., and Nosanchuk, J. D. (2009). Methampheta-mine enhances histoplasmosis by immunosuppression of the host. J. Infect. Dis. 200, 131-141.
58. Medoff, G., Kobayashi, G. S., Painter, A., and Travis, S. (1987). Morphogenesis and pathogenicity of Histo-plasma capsulatum. Infect. Immun. 55, 1355-1358.
59. Meloan, E. L. (1952). Histoplasmosis. Miss. Doct. 29, 256-257.
60. Mukherjee, J., Nussbaum, G., Scharff, M. D., and Casadevall, A. (1995a). Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181, 405-409.
61. Mukherjee, J., Scharff, M. D., and Casadevall, A. (1995b). Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect. Immun. 63, 3353-3359.
62. Mukherjee, J., Scharff, M. D., and Casadevall, A. (1992). Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60, 4534-4541.
63. Newman, S. L. (2005). Interaction of Histoplasma capsulatum with human macrophages, dendritic cells, and neutrophils. Methods Mol. Med. 118, 181-191.
64. Nimrichter, L., Rodrigues, M. L., Rodrigues,E. G., and Travassos, L. R. (2005). The multitude of targets for the immune system and drug therapy in the fungal cell wall. Microbes Infect. 7, 789-798.
65. Nosanchuk, J. D., Gomez, B. L., Youngchim, S., Diez, S., Aisen, P., Zancope-Oliveira, R. M., Restrepo, A., Casadevall, A., and Hamilton, A. J. (2002). Histoplasma capsula-tum synthesizes melanin-like pigments in vitro and during mammalian infection. Infect. Immun. 70, 5124-5131.
66. Nosanchuk, J. D., Steenbergen, J. N., Shi, L., Deepe, G. S. Jr., and Casadevall, A. (2003). Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J. Clin. Invest. 112, 1164-1175.
67. Pessolani, M. C., Hunter, S. W., and Brennan, P. J. (1993). Relationship between host histones and armadillo-derived Mycobac-terium leprae. Int. J. Lepr. Other Mycobact. Dis. 61, 381-388.
68. Pethe, K., Puech, V., Daffe, M., Josen-hans, C., Drobecq, H., Locht, C., and Menozzi, F. D. (2001). Mycobacterium smegmatis laminin-binding glycoprotein shares epi-topes with Mycobacterium tuberculosis heparin-binding haemagglutinin. Mol. Microbiol. 39, 89-99.
69. Pfaller, M. A., and Diekema, D. J. (2010). Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 36, 1-53.
70. Pirofski, L.A., and Casadevall,A. (1996). Cryptococcus neoformans: paradigm for the role of antibody immunity against fungiZentralbl. Bakteriol. 284, 475-495.
71. Pizzini, C. V., Zancope-Oliveira, R. M., Reiss,E., Hajjeh,R., Kaufman,L.,and Peralta, J. M. (1999). Evaluation of a western blot test in an outbreak of acute pulmonary histoplasmosis. Clin. Diagn. Lab. Immunol. 6, 20-23.
72. Prado, M., Silva, M. B., Laurenti, R., Travassos, L. R., and Taborda, C. P. (2009). Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem. Inst. Oswaldo Cruz 104, 513-521.
73. Saliba, A., and Beatty, O. A. (1960). Pulmonary histoplasmosis, importance of diagnostic methods, with report of an early case. JAMA 173, 902-904.
74. San-Blas, G., Ordaz, D., and Yegres, F. J. (1978). Histoplasma capsulatum: chemical variability of the yeast cell wall. Sabouraudia 16, 279-284.
75. Sau, K., Mambula, S. S., Latz, E., Hen-neke, P., Golenbock, D. T.,and Levitz, S. M. (2003). The antifungal drug amphotericin B promotes inflammatory cytokine release by a Tolllike receptor- and CD14-dependent mechanism. J. Biol. Chem. 278, 37561-37568.
76. Scheckelhoff, M., and Deepe, G. S. Jr. (2002). The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8.2+ T cells. J. Immunol. 169, 5818-5826.
77. Scheckelhoff, M., and Deepe, G. S. Jr. (2005). A deficiency in gamma interferon or interleukin-10 modulates T-cell-dependent responses to heat shock protein 60 from Histo-plasma capsulatum. Infect. Immun. 73, 2129-2134.
78. Shi, L., Albuquerque, P. C., Lazar-Molnar, E., Wang, X., Santambro-gio, L., Gacser, A., and Nosanchuk, J. D. (2008). A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages. Eukaryot. Cell 7, 1109-1117.
79. Shimoji, Y., Ng, V., Matsumura, K., Fischetti, V. A., and Rambukkana, A. (1999). A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc. Natl. Acad. Sci. U.S.A. 96, 9857-9862.
80. Smith, C. D. (1971a). "Nutritional factors that are required for the growth and sporulation of Histoplasma cap-sulatum," i n Histoplasmosis: Proceedings of the Second National Conference, eds L. Ajello, E. W. Chick, and M. L. Furcolow (Springfield: C. Thomas), 64-70.
81. Smith, C. D. (1971b). "The role of birds in the ecology of Histoplasma cap-sulatum," i n Histoplasmosis: Proceedings of the Second National Conference, eds L. Ajello, E. W. Chick, and M. L. Furcolow (Springfield: C. Thomas), 140-148.
82. Strasser, J. E., Newman, S. L., Ciraolo, G. M., Morris, R. E., Howell, M. L., and Dean, G. E. (1999). Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J. Immunol. 162, 6148-6154.
83. Taborda, C. P., and Casadevall, A. (2001). Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J. Immunol. 166, 2100-2107.
84. Taborda, C. P., Rivera, J., Zaragoza, O., and Casadevall, A. (2003). More is not necessarily better: prozone-like effects in passive immunization with IgG. J. Immunol. 170, 3621-3630.
85. Tewari, R. P., Sharma, D., Solotorovsky, M., Lafemina, R., and Balint, J. (1977). Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histo-plasma capsulatum. Infect. Immun. 15, 789-795.
86. Vecchiarelli, A., and Casadevall, A. (1998). Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity. Res. Immunol. 149, 321-333.
87. Wheat, L. J., Freifeld, A. G., Kleiman, M. B., Baddley, J. W., Mckinsey, D. S., Loyd, J. E., and Kauffman, C. A. (2007). Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 45, 807-825.
88. Wheat, L. J., and Kauffman, C. A. (2003). Histoplasmosis. Infect. Dis. Clin. North Am. 17, 1-19.
89. Yuan, R. R., Casadevall, A., Oh, J., and Scharff, M. D. (1997). T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. U.S.A. 94, 2483-2488.
90. Zaragoza, O., Alvarez, M., Telzak, A., Rivera, J., and Casadevall, A. (2007). The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. Infect. Immun. 75, 2729-2739.
91. Zeidberg, L. D., Ajello, L., Dillon, A., and Runyon, L. C. (1952). Isolation of Histoplasma capsulatum from soil. Am. J. Public Health 42, 930-935.